Europe Acute Heart Failure Epidemiology and Patient Flow Analysis - 2017

Europe Acute Heart Failure Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Acute Heart Failure patients study in a new report ‘Europe Acute Heart Failure Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Acute Heart Failure epidemiology, Acute Heart Failure diagnosed patients, and Acute Heart Failure treatment rate for EU5 pharmaceutical markets. The study measures key indicators such as prevalence of Acute Heart Failure derived from epidemiological analysis, percentage of patients diagnosed with Acute Heart Failure, and percentage of patients treated with a therapy.

The study helps executives estimate Acute Heart Failure market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Acute Heart Failure prevalence, Acute Heart Failure diagnosis rate, and Acute Heart Failure treatment rate for the period 2016 - 2025. The information is presented by leading geographies including Germany, France, Spain, Italy, and UK. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

• Acute Heart Failure Patient Flow
• Acute Heart Failure Prevalence
• Acute Heart Failure Diagnosed Patients
• Acute Heart Failure Treated Patients